| HUMAN ACTIVIN A |
HUMAN ACTIVIN A |
1381885-28-4 |
| YH239-EE |
[N/A] |
1364488-67-4 |
| 2-Fluoro-4'-[[4-(4-pyridinylMethyl)-1-piperazinyl]Methyl]-α,α-bis(trifluoroMethyl)-[1,1'-biphenyl]-4-Methanol |
化合物 T16929 |
1359164-11-6 |
| PF-04554878 |
DEFACTINIB (VS-6063, PF-04554878) |
1345713-71-4 |
| Scrambled 10Panx |
SCPANX |
1315378-72-3 |
| ROCK-II inhibitor |
(3S)-N-[2-[2-(二甲基氨基)乙氧基]-4-(1H-吡唑-4-基)苯基]-3,4-二氢-6-甲氧基-2H-1-苯并吡喃-3-甲酰胺 |
1273579-40-0 |
| (S)-2-nitro-6-((6-(4-(trifluoroMethoxy)phenyl)pyridin-3-yl)Methoxy)-6,7-dihydro-5H-iMidazo[2,1-b][1,3]oxazine |
TBA-354 |
1257426-19-9 |
| RN486 |
RN 486 |
1242156-23-5 |
| CPI 360 |
1802175-06-9 |
1802175-06-9 |
| Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,4-dichlorophenyl)-8-ethyl-2-[[3-fluoro-4-(1-piperazinyl)phenyl]aMino]- |
FRAX486 |
1232030-35-1 |
| AZD3264 |
AZD3264 |
1609281-86-8 |
| NVP-TNKS656 |
NVP-TNKS656 |
1419949-20-4 |
| CCT 244747 |
3-[(1R)-2-(二甲基氨基)-1-甲基乙氧基]-5-[[4-甲氧基-5-(1-甲基-1H-吡唑-4-基)-2-吡啶基]氨基]-2-吡嗪甲腈 |
1404095-34-6 |
| N-[2-[[(2,3-Difluorophenyl)methyl]thio]-6-[[(1S,2R)-2,3-dihydroxy-1-methylpropyl]amino]-4-pyrimidinyl]-1-azetidinesulfonamide |
N-[2-[[(2,3-二氟苯基)甲基]硫基]-6-[[(1S,2R)-2,3-二羟基-1-甲基丙基]氨基]-4-嘧啶基]-1-氮杂环丁烷磺酰胺 |
1204707-73-2 |
| AMG 232 |
2-((3R,5R,6S)-5-(3-氯苯基)-6-(4-氯苯基)-1-((S)-1-(异丙基磺酰基)-3-甲基丁烷-2-基)-3-甲基-2-氧代哌啶-3-基)乙酸 |
1352066-68-2 |
| AC710 |
N-[4-[[[[5-(叔丁基)-3-异恶唑基]氨基]羰基]氨基]苯基]-5-[(1-乙基-2,2,6,6-四甲基-4-哌啶基)氧基]-2-吡啶甲酰胺 |
1351522-04-7 |
| CL-82198 |
CL-82198 |
1188890-36-9 |
| KN-92 |
KN-92 |
1283519-40-3 |
| N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide |
N-[(1S)-1-(氨基羰基)-2-甲基丙基]-1-[(4-氟苯基)甲基]-1H-吲唑-3-甲酰胺 |
1185282-01-2 |
| EMD638683 |
3,5-二氟-ALPHA-羟基-苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰)酰肼 |
1181770-72-8 |
